Cargando…

Dipyrone/interferon-β-1b interactions: Haematological toxicity following drug interactions and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298973/ http://dx.doi.org/10.1007/s40278-021-99462-x

Ejemplares similares

Dipyrone: Toxic epidermal necrolysis: case report
Publicado: (2022)

Multiple drugs: Various toxicities following interaction and off-label: 2 case reports
Publicado: (2020)

Fluvoxamine/theophylline: Various toxicities following drug interaction and off-label use: case report
Publicado: (2022)

Dipyrone: Agranulocytosis: 3 case report
Publicado: (2021)

Multiple drugs: Various toxicities, off-label use, and drug overdose due to drug interaction: case report
Publicado: (2020)

Multiple drugs: Various toxicities, lack of efficacy, off-label use and drug interactions: 4 case reports
Publicado: (2022)

Multiple drugs: Cardiac toxicities following off-label treatment: 3 case reports
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Multiple drug interactions: QTc time prolongation following off-label use: 3 case reports
Publicado: (2022)

Ciclosporin/interferon-beta-1a: Various toxicities and off-label use: case report
Publicado: (2022)

Evaluation of immediate allergic reactions to dipyrone using dipyrone metabolites in basophil activation test
por: Montanez, Maria Isabel, et al.
Publicado: (2014)

Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)

Multiple drugs: Various toxicities following off-label use and lack-of-efficacy: case report
Publicado: (2021)

Multiple drugs: Various toxicities, and lack of efficacy following off-label use: case report
Publicado: (2022)

Dipyrone/filgrastim: Neutropenia, agranulocytosis and lack of efficacy: 3 case reports
Publicado: (2021)

Effects of dipyrone on the digestive tract
por: Collares, E.F., et al.
Publicado: (2019)

Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2022)

Chloroquine: Cardiac toxicity following off label use: case report
Publicado: (2021)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report
Publicado: (2021)

Multiple drugs interaction: Serotonin syndrome and off-label use: 2 case reports
Publicado: (2020)

Interferon-alpha-2b/oseltamivir/umifenovir: Worsening of liver function impairment following exposure to off label drugs in pregnancy: case report
Publicado: (2020)

Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022)

Lopinavir/ritonavir/sirolimus interaction: Hepatitis following an off-label use: case report
Publicado: (2022)

Multiple drugs: COVID-19, off label use and increased serum tacrolimus level following interaction: case report
Publicado: (2021)

Dipyrone/prednisolone/prednisolone sodium succinate: Acute urticaria and hyperglycaemia: case report
Publicado: (2021)

Dexamethasone/interferon-beta-1a/sulfasalazine: Toxic epidermal necrolysis and off label use: case report
Publicado: (2021)

Multiple drugs: Toxic epidermal necrolysis and off label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities and off label use: 3 case reports
Publicado: (2020)

Multiple drugs: Various toxicities and off label use: 5 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: 10 case reports
Publicado: (2021)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Tocilizumab: Various toxicities following off label use: 4 case reports
Publicado: (2021)

Anakinra: Various toxicities following off label use: 7 case reports
Publicado: (2021)

Multiple drugs: Various toxicities, lack of efficacy following off label use and vaccine failure: case report
Publicado: (2022)

Multiple drugs interaction: Off-label use and increased plasma concentration of rivaroxaban: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5pd8gj94rge635jt4pd0bdm3kk